Latest Articles
FDA approves MSD’s KEYTRUDA for endometrial carcinoma - Pharmaceutical Technology
FDA approves MSD’s KEYTRUDA for endometrial carcinoma Pharmaceutical Technology
Published: June 18, 2024, 7 a.m.
FDA Approves Pembrolizumab With Chemotherapy in Advanced Endometrial Carcinoma - AJMC.com Managed Markets Network
FDA Approves Pembrolizumab With Chemotherapy in Advanced Endometrial Carcinoma AJMC.com Managed Markets Network
Published: June 17, 2024, 7 a.m.
Corded and Hyalinized Endometrioid Endometrial Carcinoma: A Rare Case Treated With Robot-Assisted Surgery - Cureus
Corded and Hyalinized Endometrioid Endometrial Carcinoma: A Rare Case Treated With Robot-Assisted Surgery Cureus
Published: June 12, 2024, 7 a.m.
Upregulation of sperm-associated antigen 5 expression in endometrial carcinoma was associated with poor prognosis and immune dysregulation, and promoted cell migration and invasion - Nature.com
Upregulation of sperm-associated antigen 5 expression in endometrial carcinoma was associated with poor prognosis and immune dysregulation, and promoted cell migration and invasion Nature.com
Published: June 11, 2024, 7 a.m.
NLRC5 promotes endometrial carcinoma progression by regulating NF-κB pathway-mediated mismatch repair gene deficiency - Nature.com
NLRC5 promotes endometrial carcinoma progression by regulating NF-κB pathway-mediated mismatch repair gene deficiency Nature.com
Published: May 30, 2024, 7 a.m.
Delayed metastatic endometrial carcinoma mimicking primary colon adenocarcinoma: A surprise histopathological finding - Wiley Online Library
Delayed metastatic endometrial carcinoma mimicking primary colon adenocarcinoma: A surprise histopathological finding Wiley Online Library
Published: May 27, 2024, 7 a.m.
Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response - Nature.com
Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response Nature.com
Published: April 2, 2024, 7 a.m.
A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma - Nature.com
A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma Nature.com
Published: March 13, 2024, 7 a.m.
Renal Endometriosis Mimics Renal Cell Carcinoma in a Hypoplastic Kidney: A Case Report - Cureus
Renal Endometriosis Mimics Renal Cell Carcinoma in a Hypoplastic Kidney: A Case Report Cureus
Published: Feb. 29, 2024, 8 a.m.
Synchronous endometrial and ovarian carcinoma, endometrioid type – a pathologist’s insight. Case report - MedicHub
Synchronous endometrial and ovarian carcinoma, endometrioid type – a pathologist’s insight. Case report MedicHub
Published: Jan. 9, 2024, 7:09 p.m.
Link copied to clipboard!